nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxacurium chloride—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—COMT—conduct disorder	0.102	0.102	CbGpPWpGaD
Doxacurium chloride—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—conduct disorder	0.101	0.101	CbGpPWpGaD
Doxacurium chloride—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0481	0.0481	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0409	0.0409	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0389	0.0389	CbGpPWpGaD
Doxacurium chloride—CHRND—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0362	0.0362	CbGpPWpGaD
Doxacurium chloride—BCHE—Peptide hormone metabolism—CGA—conduct disorder	0.0341	0.0341	CbGpPWpGaD
Doxacurium chloride—CHRM2—Monoamine GPCRs—DRD4—conduct disorder	0.031	0.031	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0308	0.0308	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0292	0.0292	CbGpPWpGaD
Doxacurium chloride—CHRND—Neuronal System—GABRA2—conduct disorder	0.0277	0.0277	CbGpPWpGaD
Doxacurium chloride—CHRM2—Amine ligand-binding receptors—DRD4—conduct disorder	0.0261	0.0261	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Neuronal System—GABRA2—conduct disorder	0.0236	0.0236	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Neuronal System—GABRA2—conduct disorder	0.0224	0.0224	CbGpPWpGaD
Doxacurium chloride—CHRM2—Monoamine GPCRs—HTR2A—conduct disorder	0.0202	0.0202	CbGpPWpGaD
Doxacurium chloride—CHRND—Transmission across Chemical Synapses—COMT—conduct disorder	0.0174	0.0174	CbGpPWpGaD
Doxacurium chloride—CHRND—Transmission across Chemical Synapses—MAOA—conduct disorder	0.0173	0.0173	CbGpPWpGaD
Doxacurium chloride—CHRM2—Amine ligand-binding receptors—HTR2A—conduct disorder	0.017	0.017	CbGpPWpGaD
Doxacurium chloride—BCHE—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0161	0.0161	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Transmission across Chemical Synapses—COMT—conduct disorder	0.0148	0.0148	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.0147	0.0147	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Transmission across Chemical Synapses—COMT—conduct disorder	0.0141	0.0141	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.014	0.014	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCRs, Other—DRD4—conduct disorder	0.0138	0.0138	CbGpPWpGaD
Doxacurium chloride—CHRND—Neuronal System—COMT—conduct disorder	0.0133	0.0133	CbGpPWpGaD
Doxacurium chloride—CHRM2—Regulation of Actin Cytoskeleton—WASF1—conduct disorder	0.0133	0.0133	CbGpPWpGaD
Doxacurium chloride—CHRND—Neuronal System—MAOA—conduct disorder	0.0132	0.0132	CbGpPWpGaD
Doxacurium chloride—BCHE—Neuronal System—GABRA2—conduct disorder	0.0124	0.0124	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Neuronal System—COMT—conduct disorder	0.0113	0.0113	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Neuronal System—MAOA—conduct disorder	0.0113	0.0113	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Neuronal System—COMT—conduct disorder	0.0108	0.0108	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Neuronal System—MAOA—conduct disorder	0.0107	0.0107	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.00951	0.00951	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00915	0.00915	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCRs, Other—HTR2A—conduct disorder	0.00898	0.00898	CbGpPWpGaD
Doxacurium chloride—BCHE—Transmission across Chemical Synapses—COMT—conduct disorder	0.00776	0.00776	CbGpPWpGaD
Doxacurium chloride—BCHE—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00771	0.00771	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00745	0.00745	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00716	0.00716	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—CGA—conduct disorder	0.00697	0.00697	CbGpPWpGaD
Doxacurium chloride—CHRM2—G alpha (i) signalling events—DRD4—conduct disorder	0.00645	0.00645	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—CGA—conduct disorder	0.00644	0.00644	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00598	0.00598	CbGpPWpGaD
Doxacurium chloride—BCHE—Neuronal System—COMT—conduct disorder	0.00595	0.00595	CbGpPWpGaD
Doxacurium chloride—BCHE—Neuronal System—MAOA—conduct disorder	0.00591	0.00591	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00584	0.00584	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00512	0.00512	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—CGA—conduct disorder	0.00394	0.00394	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.0039	0.0039	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—DRD4—conduct disorder	0.0039	0.0039	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—CGA—conduct disorder	0.00358	0.00358	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00334	0.00334	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—CGA—conduct disorder	0.00332	0.00332	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00309	0.00309	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—HTR2A—conduct disorder	0.00255	0.00255	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—DRD4—conduct disorder	0.00221	0.00221	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—CGA—conduct disorder	0.00211	0.00211	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—DRD4—conduct disorder	0.002	0.002	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—WASF1—conduct disorder	0.00169	0.00169	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—COMT—conduct disorder	0.0015	0.0015	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—MAOA—conduct disorder	0.00149	0.00149	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00144	0.00144	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—HTR2A—conduct disorder	0.00144	0.00144	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—HTR2A—conduct disorder	0.00131	0.00131	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—DRD4—conduct disorder	0.00118	0.00118	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—HTR2A—conduct disorder	0.000772	0.000772	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—EP300—conduct disorder	0.000642	0.000642	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—EP300—conduct disorder	0.000409	0.000409	CbGpPWpGaD
